Belite Bio (BLTE) Current Assets (2021 - 2025)

Belite Bio has reported Current Assets for 5 years, with the latest figure at $494.3 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 236.07% year-over-year to $494.3 million; the trailing twelve-month figure through Dec 2025 stood at $494.3 million (up 236.07% YoY), and the FY2025 full-year result was $494.3 million, up 236.07% from the prior year.
• Current Assets for Q4 2025 stood at $494.3 million, up from $147.1 million in the prior quarter.
• The five-year high for Current Assets was $494.3 million in Q4 2025, with the low at $17.4 million in Q4 2021.
• Average Current Assets over 5 years is $158.3 million, with a median of $89.9 million recorded in 2023.
• Year-over-year, Current Assets soared 63.52% in 2024 and surged 236.07% in 2025.
• Tracing BLTE's Current Assets over 5 years: stood at $17.4 million in 2021, then soared by 145.58% to $42.8 million in 2022, then jumped by 110.11% to $89.9 million in 2023, then soared by 63.52% to $147.1 million in 2024, then surged by 236.07% to $494.3 million in 2025.
• The last three Current Assets figures came in at $494.3 million (Q4 2025), $147.1 million (Q4 2024), and $89.9 million (Q4 2023), per Business Quant data.

Peer Comparison